title: Chemotherapy maintenance: an option for prolonged survival in  malignant peritoneal mesothelioma?
authors.affiliation: Department of Medical Oncology, University Hospital Zürich, Zürich, Switzerland. silvia.hofer@usz.ch
authors.forename: Silvia
authors.initials: S
authors.lastname: Hofer
authors.forename: Bernd
authors.initials: B
authors.lastname: Sasse
authors.forename: Hans
authors.initials: H
authors.lastname: Scheffel
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D005971:Glutamates / Q000627:therapeutic use*; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D000068437:Pemetrexed; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014057:Tomography, X-Ray Computed
chemical_list: D000964:Antimetabolites, Antineoplastic; D005971:Glutamates; D000068437:Pemetrexed; D006147:Guanine